Drug Trial Radar · NCT01002911
Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)
Last checked: Nov 19, 2026Latest source record: May 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Dec 2009
Primary completion
Jan 2012
Study completion Jan 2012
Sponsor
- Lead sponsor
- Population Health Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 28, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of the pilot study is to compare conventional antibiotic therapy to an aggressive antibiotic therapy plan for the prevention of arrhythmia device infection in high-risk patients undergoing arrhythmia device procedures. All antibiotics are approved for use and readily available.
Conditions
- Arrythmias
Interventions
Cefazolin, Bacitracin, CefalexinDrug
Single does of Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision, Bacitracin wash, Cefalexin 250-500 mg TID
CefazolinDrug
Cefazolin 1-2 g iv given over 60-120 minutes, 60-120 minutes prior to skin incision
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hospitalization attributed to device infection.Time frame: Patients will have one follow-up visit at 12 months or earlier should a primary outcome event occur.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institut universitaire de cardiologie et de pneumologie de Quebec
Ste-Foy, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.